Rasna Therapeutics Inc. | Income Statement
Fiscal year is July-June. All values USD Thousands.
2013
2014
2015
2016
SG&A Expense
5.40
40.00
16.80
62.20
EBIT
5.40
40.00
16.80
62.20
Pretax Income
5.40
40.00
16.80
62.20
Consolidated Net Income
5.40
40.00
16.80
62.20
Net Income
5.40
40.00
16.80
62.20
Net Income After Extraordinaries
5.40
40.00
16.80
62.20
Net Income Available to Common
5.40
40.00
16.80
62.20
EPS (Basic)
0.00
0.01
0.00
0.01
Basic Shares Outstanding
10,741.30
10,741.30
10,741.30
10,741.30
EPS (Diluted)
0.00
0.00
0.00
0.01
Diluted Shares Outstanding
10,741.30
10,741.30
10,741.30
10,741.30
EBITDA
5.40
40.00
16.80
62.20
About Rasna Therapeutics
View Profile
